Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

A rare genetic mutation causes severe immune issues, hair loss, and nail problems.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Early diagnosis and nutritional support are crucial for managing Cronkhite-Canada Syndrome.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

The protein p21 is more abundant in normal skin cells than in melanoma cells and may help protect against melanoma, with UVB light affecting its levels.

Vitamin C derivative reduces hair loss-related protein in cells.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

A 20-month-old girl had a rare adrenal tumor removed successfully, with no recurrence for 10 years.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Clitocybin A can promote hair growth by increasing cell proliferation.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

A man's adrenal insufficiency was caused by a pituitary tumor linked to kidney cancer.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

The method increases stem-like cells for better skin regeneration.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.